Abstract
Purpose
To establish which patients undergoing pancreaticoduodenectomy (PD) need autologous blood storage and transfusion.
Methods
Autologous blood was collected and stored for 69 patients scheduled to undergo PD, and not used in 50 patients. Based on the use of the deposited autologous blood and the estimated postoperative hemoglobin (Hb) level when blood was not deposited, we divided the patients into a “transfusion necessary” group and a “transfusion unnecessary” group. By comparing the two groups, we proposed a method of scoring to predict the necessity for storing autologous blood.
Results
The “transfusion necessary” group comprised 6 patients (2 who received homologous blood transfusion and 4 with an estimated postoperative Hb of <8.0 g/dL) and the “transfusion unnecessary” group comprised 63 patients (24 whose autologous blood was discarded and 39 with an estimated Hb ≥8.0 g/dL). By analyzing the differences between the groups, including the preoperative hemoglobin level and the need for portal vein resection, we devised a scoring system to predict the necessity of collecting autologous blood. The scoring significantly correlated with the proportion of patients who did not require autologous blood storage and transfusion.
Conclusions
Not all patients benefited from autologous blood storage and transfusion. Our scoring system proved useful for identifying which patients required autologous blood storage and transfusion during PD.
Similar content being viewed by others
References
Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med. 1994;118:371–9.
Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts—blood transfusion. N Engl J Med. 1999;340:438–47.
Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.
Sutton JM, Kooby DA, Wilson GC, Squires MH 3rd, Hanseman DJ, Maithel SK, et al. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg. 2014;18:1575–87.
Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med. 1993;328:1372–6.
Bortul M, Calligaris L, Roseano M, Leggeri A. Blood transfusions and results after curative resection for gastric cancer. Suppl Tumori. 2003;2:S27–30.
Komatsu Y, Orita H, Sakurada M, Maekawa H, Hoppo T, Sato K. Intraoperative blood transfusion contributes to decreased long-term survival of patients with esophageal cancer. World J Surg. 2012;36:844–50.
Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, et al. Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol. 2011;17:3709–15.
Arima K, Hashimoto D, Okabe H, Inoue R, Kaida T, Higashi T, et al. Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer. Surg Today. 2016;46:792–7.
Mizuguchi T, Torigoe T, Satomi F, Shima H, Kutomi G, Ota S, et al. Trials of vaccines for pancreatic ductal adenocarcinoma: is there any hope of an improved prognosis? Surg Today. 2016;46:139–48.
Goodnough LT. Autologous blood donation. Crit Care. 2004;8(Suppl 2):S49–52.
Thomas MJ, Gillon J, Desmond MJ. Consensus conference on autologous transfusion. Preoperative autologous donation. Transfusion. 1996;36:633–9.
Cohen JA, Brecher ME. Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion. 1995;35:640–4.
Kasper SM, Ellering J, Stachwitz P, Lynch J, Grunenberg R, Buzello W. All adverse events in autologous blood donors with cardiac disease are not necessarily caused by blood donation. Transfusion. 1998;38:669–73.
Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of two parts—blood conservation. N Engl J Med. 1999;340:525–33.
Tomimaru Y, Eguchi H, Wada H, Hama N, Kawamoto K, Kobayashi S, et al. Predicting the necessity of autologous blood collection and storage before surgery for hepatocellular carcinoma. J Surg Oncol. 2013;108:486–91.
Couvret C, Tricoche S, Baud A, Dabo B, Buchet S, Palud M, et al. The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty: the effect on subsequent transfusion rates. Anesth Analg. 2002;94:815–23 (table of contents).
Basran S, Frumento RJ, Cohen A, Lee S, Du Y, Nishanian E, et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg. 2006;103:15–20 (table of contents).
Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229–39.
Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion. 1995;35:734–7.
Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med. 1995;332:719–24.
Kruskall MS. Cost effectiveness of autologous blood donation. N Engl J Med. 1995;333:461–2 (author reply 3).
Brecher ME, Goodnough LT. The rise and fall of preoperative autologous blood donation. Transfusion. 2001;41:1459–62.
Vanderlinde ES, Heal JM, Blumberg N. Autologous transfusion. BMJ. 2002;324:772–5.
Carless P, Moxey A, O’Connell D, Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med. 2004;14:123–44.
Heiss MM, Fasol-Merten K, Allgayer H, Strohlein MA, Tarabichi A, Wallner S, et al. Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. Vox Sang. 1997;73:237–45.
Sagawa K, Omokawa S, Furukawa Y. New guideline for autologous blood transfusion (in Japanese). J Jpn Soc Autologous Blood Transfus. 2007;20:10–34.
Japanese Ministry of Health LaW. Blood transfusion guideline (in Japanese). 3rd ed. Tokyo: Jiho Co; 2005.
Itamoto T, Katayama K, Nakahara H, Tashiro H, Asahara T. Autologous blood storage before hepatectomy for hepatocellular carcinoma with underlying liver disease. Br J Surg. 2003;90:23–8.
Pulitano C, Arru M, Bellio L, Rossini S, Ferla G, Aldrighetti L. A risk score for predicting perioperative blood transfusion in liver surgery. Br J Surg. 2007;94:860–5.
Lennox PA, Clugston PA, Beasley ME, Bostwick J 3rd. Autologous blood transfusion in TRAM breast reconstruction: is it necessary? Ann Plast Surg. 2004;53:532–5.
Vega SJ, Nguyen TV, Forsberg C, Hua LB, Kirkley SA, Herrera HR, et al. Efficacy of preoperative autologous blood donation in free TRAM flap breast reconstruction. Plast Reconstr Surg. 2008;121:241e–6e.
Billote DB, Abdoue AG, Wixson RL. Comparison of acute normovolemic hemodilution and preoperative autologous blood donation in clinical practice. J Clin Anesth. 2000;12:31–5.
Weber RS, Jabbour N, Martin RC 2nd. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol. 2008;15:34–45.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Yoshito Tomimaru and his co-authors have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Tomimaru, Y., Noguchi, K. & Dono, K. Necessity for autologous blood storage and transfusion in patients undergoing pancreatoduodenectomy. Surg Today 47, 568–574 (2017). https://doi.org/10.1007/s00595-016-1407-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-016-1407-4